Ellen Werble
@ellen-werblehp.bsky.social
Health policy and budget wonk. After 14 years working for the health team at the Congressional Budget Office, I started my own consulting firm: Werble Health Policy. Also on LinkedIn
Reposted by Ellen Werble
First Q from advisory panel: - how would new regulatory framework impacts this, if new strain selected, would that require new trials?...
FDA's Jerry Weir said too premature too discuss this. - question off topic.
I don't see how this is off topic. #healthpolicy
FDA's Jerry Weir said too premature too discuss this. - question off topic.
I don't see how this is off topic. #healthpolicy
May 22, 2025 at 12:59 PM
First Q from advisory panel: - how would new regulatory framework impacts this, if new strain selected, would that require new trials?...
FDA's Jerry Weir said too premature too discuss this. - question off topic.
I don't see how this is off topic. #healthpolicy
FDA's Jerry Weir said too premature too discuss this. - question off topic.
I don't see how this is off topic. #healthpolicy
Reposted by Ellen Werble
“In foreign countries, the vaccines are more broadly approved, similar to what FDA has done in the past, and then restricted on public health grounds. That’s where CDC could have stepped in, had FDA not usurped its role.”
May 21, 2025 at 12:33 PM
“In foreign countries, the vaccines are more broadly approved, similar to what FDA has done in the past, and then restricted on public health grounds. That’s where CDC could have stepped in, had FDA not usurped its role.”
Reposted by Ellen Werble
A technical footnote for the wonks: CBO has not yet estimated the interaction with 1 million more uninsured from the Energy and Commerce ACA changes and 2.1 million from the Ways and Means ACA changes. So, the net change might be somewhat different from the sum of the two.
May 20, 2025 at 5:51 PM
A technical footnote for the wonks: CBO has not yet estimated the interaction with 1 million more uninsured from the Energy and Commerce ACA changes and 2.1 million from the Ways and Means ACA changes. So, the net change might be somewhat different from the sum of the two.
Reposted by Ellen Werble
Graham on user fees: its worth exploring whether and how restructuring and simplifying the user fee programs may help rebuild trust in the FDA and its decisions and take advantage of the upcoming reauthorization to do so.
May 16, 2025 at 2:48 PM
Graham on user fees: its worth exploring whether and how restructuring and simplifying the user fee programs may help rebuild trust in the FDA and its decisions and take advantage of the upcoming reauthorization to do so.